Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial.

Saved in:
Bibliographic Details
Title: Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial.
Authors: Kang J; Seoul National University Hospital, Seoul, South Korea; Seoul National University College of Medicine, Seoul, South Korea., Park KW; Seoul National University Hospital, Seoul, South Korea; Seoul National University College of Medicine, Seoul, South Korea., Han JK; Seoul National University Hospital, Seoul, South Korea; Seoul National University College of Medicine, Seoul, South Korea., Hwang D; Seoul National University Hospital, Seoul, South Korea; Seoul National University College of Medicine, Seoul, South Korea., Yang HM; Seoul National University Hospital, Seoul, South Korea; Seoul National University College of Medicine, Seoul, South Korea., Park S; Seoul National University Hospital, Seoul, South Korea; Seoul National University College of Medicine, Seoul, South Korea., Ahn HS; Uijeongbu St Mary's Hospital, Seoul, South Korea., Hwang KK; Chungbuk National University Hospital, Cheongju, South Korea., Kim BG; Sanggye Paik Hospital, Seoul, South Korea., Jeong JO; Chungnam National University Hospital, Daejeon, South Korea., Ahn JH; Gyeongsang National University Changwon Hospital, Changwon, South Korea., Rhew JY; Presbyterian Medical Center, Jeonju, South Korea., Park H; Gangneung Asan Hospital, Gangneung, South Korea., Kang TS; Dankook University Hospital, Cheonan, South Korea., Koh JS; Gyeongsang National University Hospital, Jinju, South Korea., Park KT; Chung-Ang University Hospital, Seoul, South Korea., Bang DW; Soonchunhyang University Seoul Hospital, Seoul, South Korea., Goh CW; Ewha Womans University Seoul Hospital, Seoul, South Korea., Yoon HJ; Keimyung University Dongsan Hospital, Daegu, South Korea., Jo SH; Hallym University Sacred Heart Hospital, Anyang, South Korea., Jang JY; National Health Insurance Service Ilsan Hospital, Goyang, South Korea., Choi YJ; Sejong General Hospital, Bucheon, South Korea., Lee SR; Jeonbuk National University Hospital, Jeonju, South Korea., Lim YH; Hanyang University Seoul Hospital, Seoul, South Korea., Kim HS; Seoul National University Hospital, Seoul, South Korea; Seoul National University College of Medicine, Seoul, South Korea. Electronic address: hyosoo@snu.ac.kr.
Corporate Authors: HOST-BR investigators
Source: Lancet (London, England) [Lancet] 2025 Nov 08; Vol. 406 (10516), pp. 2244-2256. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-547X
DOI:10.1016/S0140-6736(25)01571-5